SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-030956
Filing Date
2023-05-19
Accepted
2023-05-19 16:05:38
Documents
1
Period of Report
2023-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5791
  Complete submission text file 0001209191-23-030956.txt   7363
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063
Business Address
Orwin John A (Reporting) CIK: 0001477384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 23940014